Sun Pharmaceutical Industries Limited has informed the Exchange about Schedule of meet
SUNPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sun Pharmaceutical Industries has informed the stock exchanges about two upcoming investor meetings scheduled in early September 2025. The first is the Motilal Oswal 21st Annual Global Investor Conference on September 1, followed by the Ashwamedh – Elara India Dialogue 2025 on September 2, both to be held physically in Mumbai. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be shared at these meetings. The disclosure is filed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements, signed by Company Secretary Anoop Deshpande. The schedule is subject to change due to last-minute exigencies.
This is a routine regulatory disclosure with no new business or financial information, so it is unlikely to move the stock price. It does signal that the company is actively engaging with the investor community, which supports transparency and visibility.